We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$40.2B
AUM Growth
-$933M
Cap. Flow
-$563M
Cap. Flow %
-1.4%
Top 10 Hldgs %
41.26%
Holding
326
New
14
Increased
66
Reduced
135
Closed
15

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$382M
2
ETN icon
Eaton
ETN
+$274M
3
NVDA icon
NVIDIA
NVDA
+$110M
4
LLY icon
Eli Lilly
LLY
+$40.2M
5
NOW icon
ServiceNow
NOW
+$32.3M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$194M
2
UNP icon
Union Pacific
UNP
+$185M
3
AZN icon
AstraZeneca
AZN
+$164M
4
MSFT icon
Microsoft
MSFT
+$81.1M
5
V icon
Visa
V
+$76.3M

Sector Composition

Rank Sector Weight
1 Technology 27.83%
2 Financials 19.19%
3 Consumer Staples 12.47%
4 Healthcare 10.91%
5 Energy 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CR icon
201
Crane Co
CR
$11.5B
$781K ﹤0.01%
5,099
– –
IJK icon
202
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.4B
$770K ﹤0.01%
9,249
-700
-7% -$63.1K
CRM icon
203
Salesforce
CRM
$214B
$768K ﹤0.01%
2,860
+114
+4% +$35.5K
GIS icon
204
General Mills
GIS
$19.5B
$760K ﹤0.01%
12,715
-1,700
-12% -$102K
EW icon
205
Edwards Lifesciences
EW
$49.3B
$759K ﹤0.01%
10,477
-3,278
-24% -$235K
PAGP icon
206
Plains GP Holdings
PAGP
$5.54B
$709K ﹤0.01%
33,213
+20,211
+155% +$425K
MLM icon
207
Martin Marietta Materials
MLM
$35.6B
$689K ﹤0.01%
1,440
-450
-24% -$229K
ORLY icon
208
O'Reilly Automotive
ORLY
$70.6B
$683K ﹤0.01%
7,155
– –
ENB icon
209
Enbridge
ENB
$105B
$680K ﹤0.01%
15,349
-4,458
-23% -$194K
GWW icon
210
W.W. Grainger
GWW
$60.2B
$648K ﹤0.01%
656
-30
-4% -$31K
GEHC icon
211
GE HealthCare
GEHC
$29B
$645K ﹤0.01%
7,989
-1,161
-13% -$99.8K
DELL icon
212
Dell
DELL
$340B
$634K ﹤0.01%
6,953
-1
-0% -$106
GRMN
213
Garmin
GRMN
$54.1B
$633K ﹤0.01%
2,916
– –
VEA icon
214
Vanguard FTSE Developed Markets ETF
VEA
$234B
$633K ﹤0.01%
12,444
– –
CFR icon
215
Cullen/Frost Bankers
CFR
$10.2B
$609K ﹤0.01%
4,867
-25
-0.5% -$3.36K
CPB icon
216
Campbell Soup
CPB
$6.34B
$603K ﹤0.01%
15,100
– –
BRO icon
217
Brown & Brown
BRO
$22.9B
$596K ﹤0.01%
+4,790
New +$535K
PB icon
218
Prosperity Bancshares
PB
$8.59B
$595K ﹤0.01%
8,338
– –
ECL icon
219
Ecolab
ECL
$77.2B
$590K ﹤0.01%
2,326
– –
MSI icon
220
Motorola Solutions
MSI
$78.5B
$587K ﹤0.01%
1,341
– –
TJX icon
221
TJX Companies
TJX
$139B
$575K ﹤0.01%
+4,722
New +$573K
DD icon
222
DuPont de Nemours
DD
$16.8B
$571K ﹤0.01%
6,090
– –
BSX icon
223
Boston Scientific
BSX
$65.3B
$569K ﹤0.01%
5,641
+290
+5% +$29.2K
MCO icon
224
Moody's
MCO
$82.8B
$559K ﹤0.01%
1,200
– –
EXP icon
225
Eagle Materials
EXP
$5.6B
$538K ﹤0.01%
2,425
– –
7 8
9
10 11

Similar funds

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Fayez Sarofim & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Fayez Sarofim & Co held 326 positions worth $40.2B, down 2.3% from $41.1B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Fayez Sarofim & Co's Q1 2025 filing shows 14 new, 66 increased, 135 reduced and 15 closed positions. Its largest new stake was BNY Mellon Concentrated Growth ETF: 191,899 shares worth $0. The largest sale was UnitedHealth, an estimated $194M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q1 2025 buy was BNY Mellon Concentrated Growth ETF: 191,899 shares worth $0.
  • Fayez Sarofim & Co added most to Meta Platforms (Facebook) in Q1 2025, an estimated $382M increase.
  • Fayez Sarofim & Co's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $194M.
  • Fayez Sarofim & Co fully exited Brookfield in Q1 2025, selling an estimated $1.16M.
  • Fayez Sarofim & Co's ten largest holdings make up 41% of its $40.2B portfolio in Q1 2025.
  • Fayez Sarofim & Co opened 14 new positions and closed 15 in Q1 2025.
  • Fayez Sarofim & Co's portfolio value fell 2.3% quarter-over-quarter to $40.2B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2025, filed 12 May 2025.